Grant recipient

Johan Burisch

The Influence of Genetics, Immunity and Microbiome on the Prognosis of Inflammatory Bowel Disease – the IBD Prognosis Study
Grant amount: DKK 9,778,800
Johan Burisch says: “Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are chronic diseases caused by abnormal inflammation in the intestinal tract. Patients are often diagnosed in early adulthood and face a lifetime of suffering from a disease that currently has no cure. It is of major importance to identify patients at an early stage who later develop aggressive disease to offer these patients close follow-up and individually tailored medication. Currently, we do not understand why some patients experience a mild disease course and others suffer from aggressive disease. In this project, we will combine clinical, genetic, gut microbiome and serological information to be able to predict – at diagnosis – which disease path a newly diagnosed young patient will take and thereby enable physicians to choose the right treatment for the right patient and improve their disease course.”
Johan Burisch
Johan Burisch, physician, PhD
Gastrounit, Amager and Hvidovre Hospital